Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression.

by Marta Rodríguez-García, Núria Climent, Harold Oliva, Víctor Casanova, Rafael Franco, Agathe Leon, José M Gatell, Felipe García, Teresa Gallart
Published 2010-02-01

Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals.

by Víctor Casanova, Isaac Naval-Macabuhay, Marta Massanella, Marta Rodríguez-García, Julià Blanco, José M Gatell, Felipe García, Teresa Gallart, Carme Lluis, Josefa Mallol, Rafael Franco, Núria Climent, Peter J McCormick
Published 2012-01-01

Prevalence, clinical characteristics and outcome of severe primary HIV-1 infection: A prospective cohort study

by David Nicolás, Antoni Suárez, Juan Ambrosioni, Christian Manzardo, Carmen Ligero, Josep Costa, Emma Fernández, M. Ángeles Marcos, Montserrat Plana, María Mar Mosquera, Sonsoles Sánchez-Palomino, Jose M. Gatell, José M. Miró
Published 2019-11-01

Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant.

by Carolina Beltran-Pavez, Carolina B Ferreira, Alberto Merino-Mansilla, Amanda Fabra-Garcia, Maria Casadella, Marc Noguera-Julian, Roger Paredes, Alex Olvera, Isabel Haro, Christian Brander, Felipe Garcia, Jose M Gatell, Eloisa Yuste, Victor Sanchez-Merino
Published 2018-01-01

A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART.

by Carmen Elena Gómez, Beatriz Perdiguero, Juan García-Arriaza, Victoria Cepeda, Carlos Óscar Sánchez-Sorzano, Beatriz Mothe, José Luis Jiménez, María Ángeles Muñoz-Fernández, Jose M Gatell, Juan Carlos López Bernaldo de Quirós, Christian Brander, Felipe García, Mariano Esteban
Published 2015-01-01

Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers.

by Sergio Barroso, Constanza Morén, Àlex González-Segura, Neus Riba, Joan A Arnaiz, Marcela Manriquez, Gemina Santana, José L Blanco, María Larousse, Montse Loncà, Elisa de Lazzari, Jaume Llopis, Josep Mallolas, Oscar Miró, Xavier Carné, Jose M Gatell, Glòria Garrabou, Esteban Martínez
Published 2019-01-01

Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals.

by Ai Kawana-Tachikawa, Josep M Llibre, Isabel Bravo, Roser Escrig, Beatriz Mothe, Jordi Puig, Maria C Puertas, Javier Martinez-Picado, Julia Blanco, Christian Manzardo, Jose M Miro, Aikichi Iwamoto, Anton L Pozniak, Jose M Gatell, Bonaventura Clotet, Christian Brander, MARAVIBOOST Investigators
Published 2014-01-01

Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration.

by Cristina García de la Mària, Carlos Cervera, Juan M Pericàs, Ximena Castañeda, Yolanda Armero, Dolors Soy, Manel Almela, Salvador Ninot, Carlos Falces, Carlos A Mestres, Jose M Gatell, Asuncion Moreno, Francesc Marco, José M Miró, Hospital Clinic Endocarditis Study Group
Published 2015-01-01

Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.

by Alberto C Guardo, Carmen Elena Gómez, Vicens Díaz-Brito, Judit Pich, Joan Albert Arnaiz, Beatriz Perdiguero, Juan García-Arriaza, Nuria González, Carlos O S Sorzano, Laura Jiménez, José Luis Jiménez, María Ángeles Muñoz-Fernández, José M Gatell, José Alcamí, Mariano Esteban, Juan Carlos López Bernaldo de Quirós, Felipe García, Montserrat Plana, RISVAC02boost study
Published 2018-01-01

Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.

by Alberto C Guardo, Carmen Elena Gómez, Vicens Díaz-Brito, Judit Pich, Joan Albert Arnaiz, Beatriz Perdiguero, Juan García-Arriaza, Nuria González, Carlos O S Sorzano, Laura Jiménez, José Luis Jiménez, María Ángeles Muñoz-Fernández, José M Gatell, José Alcamí, Mariano Esteban, Juan Carlos López Bernaldo de Quirós, Felipe García, Montserrat Plana, RISVAC02boost study
Published 2017-01-01